Follow-The-Filings

Security · featured owners

BRKR Bruker Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 3.6%
  • $244M
  • 3 new

BRKR (Bruker Corp.) is held in 3 featured 13F books as of 2026 Q2. Sachem Head Capital Management is the largest tracked holder by portfolio weight (3.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.6% (Sachem Head Capital Management) · not free-float ownership

  1. Sachem Head Capital Management new 3.6%
  2. Glenview Capital Management new 0.28%
  3. Andreas Halvorsen new 0.15%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Sachem Head Capital Management 2026 Q2 3.6% New 3.6% 2,915,000 $175M history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.15% New 0.15% 893,491 $54M history
Glenview Capital Management 2026 Q2 0.28% New 0.28% 252,169 $15M history

3 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K/A 5.07 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
10-K Filing Doc
8-K 5.02,8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Aug 14, 2026 Filing Doc
4 Period Aug 15, 2026 · 6 forms Filing Doc
4 Period Aug 11, 2026 · 3 forms Filing Doc
4 Period Aug 9, 2026 · 3 forms Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period Apr 15, 2026 Filing Doc
4 Period Mar 13, 2026 Filing Doc
4 Period Feb 15, 2026 · 6 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.96B $3.37B $3.44B
Gross profit $1.51B $1.65B $1.58B
Gross margin * 51.0% 49.0% 45.9%
Net income $427.2M $113.1M -$8.6M
Net margin * 14.4% 3.4% -0.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.16B $2.05B $2.21B
Total non-current assets * $2.09B $3.75B $4.03B
Total assets $4.25B $5.81B $6.24B
Total current liabilities $1.2B $1.28B $1.28B
Total non-current liabilities * $1.63B $2.71B $2.45B
Total equity $1.38B $1.78B $2.46B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $350.1M $251.3M $134.1M
Cash from investing -$0.326B -$1.76B -$0.196B
Cash from financing -$0.193B $1.23B $0.135B
Net change in cash -$157.1M -$304.9M $116.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders